Non-obese men with high lipoprotein(a) values– a cardiovascular risk group different from those with the metabolic syndrome?

References

• Imperial Cancer Research Fund OXCHECK study group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ 1991; 302: 1057–60
   PubMedGoogle Scholar
• Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335: 827–38
   PubMed Web of Science ®Google Scholar
• Werkö L. The enigma of coronary heart disease and its prevention. Acta Med Scand 1987; 221: 323–33
   PubMed Web of Science ®Google Scholar
• Lind L, Jakobsson S, Lithell H, Wengle B, Ljunghall S. Relation on serum calcium to metabolic risk factors for cardiovascular disease. BMJ 1988; 297: 960–3
   PubMed Web of Science ®Google Scholar
• Reaven G. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
   PubMed Web of Science ®Google Scholar
• DeFronzo R, Feranninni E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic disease. Diabetes care 1991; 14: 173–94
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Lusky A, Segal P, Fuch Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study. Arteriosclerosis 1988; 8: 277–36
   Google Scholar
• Stout R. Insulin and atheroma, a 20-year perspective. Diabetes Care 1990; 13: 631–54
   PubMed Web of Science ®Google Scholar
• Loscalzo J. Lipoprotein(a): a unique risk factor for atherothrombotic disease. Arteriosclerosis 1990; 10: 672–9
   PubMedGoogle Scholar
• Berg K. A new serum type system in man–the Lp system. Acta Pathol Microbiol Scand 1963; 59: 369–82
   PubMedGoogle Scholar
• Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. BMJ 1990; 301: 1248–51
   PubMed Web of Science ®Google Scholar
• Haffner S M., Stern M P., Hazuda H, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before onset of clinical diabetes?. JAMA 1990; 263: 2893–8
   PubMed Web of Science ®Google Scholar
• Rhoads G, Dahlén G, Berg K, Morton N, Dannen-berg L. Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction. JAMA 1986; 256: 2540–4
   PubMed Web of Science ®Google Scholar
• British Hypertension Society. Recommendations on blood pressure measurement. BMJ 1986; 293: 611–5
   PubMedGoogle Scholar
• Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: a 13 year follow up of participants in the study of men born in 1913. BMJ 1984; 288: 1401–4
   PubMed Web of Science ®Google Scholar
• Guidelines sub-committee of the WHO/ISH mild hypertension liaison committee. 1989 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1989; 7: 689–93
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Expert Committee on Diabetes Mellitus. WHO, Geneva 1980, second report. Techn Rep Ser 646
   Google Scholar
• Dahlén G, Berg K, Ramberg U B., Tamm A. Lp(a) lipoprotein and pre-beta-1 lipoprotein in young adults. Acta Med Scand 1974; 196: 327–31
   Google Scholar
• Dahlén G, Berg K, Gillnäs T, Ericsson C. Lp(a) lipoprotein/pre-beta-1 lipoprotein in Swedish middle-aged males and in patients with coronary heart disease. Clin Genetics 1975; 7: 334–41
   Google Scholar
• Dahlén G, Berg K. Pre-Bl-lipoprotein and Lp(a) antigen in relation to triglyceride levels and insulin release following an oral glucose load in middle-aged males. Acta Med Scand 1976; 199: 413–19
   Google Scholar
• Dahlén G, Berg K. Confirmation of an influence of the inherited Lp(a) variation on serum insulin and glucose levels. Clin Genetics 1979; 16: 418–27
   Google Scholar
• Emancipator K, Elin R J. Relationship between lipoprotein(a) and other indices of cardiovascular risk. (Abstract). Clin Chem 1991; 6: 924
   Google Scholar
• Feranninni E, Buzzigoli G, Bonnadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
   PubMedGoogle Scholar
• Nilsson P, Lindholm L, Scherstén B. Independent correlations between insulin and blood pressure exist in normotensive men and women. Diabetologia 1991; 34(Suppl 2)A20, 78
   Google Scholar
• Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 1990; 39: 167–74
   PubMed Web of Science ®Google Scholar
• Sundell B, Nilsson T, Hallmans G, Hellsten G, Dahlen G. Interrelationships between plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein(a), and established cardiovascular risk factors in a North Swedish population. Arteriosclerosis 1989; 80: 9–16
   Google Scholar
• Seed M, Huppler F, Reaveley D, et al. Relation of serum lipoprotein(a) concentration and apolipo-protein(a) phenotype in coronary heart disease in patients with familiar hypercholesterolemia. N Engl J Med 1990; 322: 1494–9
   PubMed Web of Science ®Google Scholar
• Mbewu A D., Bhatnagar D, Durrington P N., et al. Serum Lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and untreated control populations. Arterioscler Thomb 1991; 11: 940–46
   PubMedGoogle Scholar
• Sidhu M, Cooke D, Godsland I F., Walton C, Wynn V, Oliver M F. Inverse relationship between serum Lp(a) levels and first-phase insulin secretion. Diabetes 1992; 41: 1341–5
   Google Scholar
• Heinrich J, Sandkamp M, Kokott R, Schulte H, Assmann G. Relationship of lipoprotein(a) to variables of coagulation and fibrinolysis in a healthy population. Clin Chem 1991; 37: 1950–4
   PubMed Web of Science ®Google Scholar
• Farrer M, Game F L., Alberts C J., et al. Association between impaired glucose tolerance and circulation concentration of Lp(a) lipoprotein in relation to coronary heart disease. BMJ 1993; 307: 832–6
   Google Scholar
• Dahlen G. Incidence of Lp(a) lipoprotein among populations. Lipoprotein(a), A M. Scanu, G Dahlen. Academic Press Inc, San Diego 1990; 40–50
   Google Scholar